Back

The association between renin-angiotensin-aldosterone system inhibitors dose reduction and risk of mortality and major adverse cardiovascular events in heart failure patients

26 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome Epidemiology, Prognosis, Outcome ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mr Daniel Ayoubkhani

Health Economics & Outcomes Research Ltd, Cardiff (United Kingdom of Great Britain & Northern Ireland)

16 More presentations in this session

Presentation thumbnail
Professor P. Myhre (Oslo, NO)
Abstract Slides
Presentation thumbnail
Doctor M. Alfarano (Rome, IT)
Abstract
Presentation thumbnail
Miss S. Duhamel (Bron, FR)
Abstract
Presentation thumbnail
Doctor T. Von Lueder (Oslo, NO)
Abstract
Presentation thumbnail
Doctor J. Lupon (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic heart failure – Epidemiology, prognosis, outcome

The Event

Event poster

ESC Congress 2018

26 August 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources